[{"address1": "345 Park Avenue South", "address2": "6th Floor", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 547 9879", "website": "https://www.lexeotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of plakophilin-2 arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of hypertrophic cardiomyopathy, or HCM caused by TNNI3 gene. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.", "fullTimeEmployees": 72, "companyOfficers": [{"maxAge": 1, "name": "Mr. R. Nolan Townsend", "age": 43, "title": "CEO & Director", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 864335, "exercisedValue": 0, "unexercisedValue": 6398299}, {"maxAge": 1, "name": "Dr. Eric  Adler M.D.", "age": 50, "title": "Chief Medical Officer & Head of Research", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 623400, "exercisedValue": 0, "unexercisedValue": 586874}, {"maxAge": 1, "name": "Ms. Jenny R. Robertson J.D.", "age": 49, "title": "Chief Business & Legal Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 617900, "exercisedValue": 0, "unexercisedValue": 94692}, {"maxAge": 1, "name": "Dr. Ronald G. Crystal M.D.", "title": "Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kyle  Rasbach Ph.D., Pharm.D.", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jose Manuel Otero Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sandi See Tai M.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  McHenry", "title": "VP & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.11, "open": 4.1, "dayLow": 3.94, "dayHigh": 4.33, "regularMarketPreviousClose": 4.11, "regularMarketOpen": 4.1, "regularMarketDayLow": 3.94, "regularMarketDayHigh": 4.33, "payoutRatio": 0.0, "forwardPE": -1.4801444, "volume": 322531, "regularMarketVolume": 322531, "averageVolume": 495929, "averageVolume10days": 1245290, "averageDailyVolume10Day": 1245290, "bid": 3.0, "ask": 5.06, "bidSize": 1, "askSize": 2, "marketCap": 136107696, "fiftyTwoWeekLow": 2.32, "fiftyTwoWeekHigh": 19.5, "fiftyDayAverage": 4.0613, "twoHundredDayAverage": 8.72345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 24513688, "profitMargins": 0.0, "floatShares": 21814743, "sharesOutstanding": 33197000, "sharesShort": 2215452, "sharesShortPriorMonth": 2310952, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.067, "heldPercentInsiders": 0.01249, "heldPercentInstitutions": 1.06055, "shortRatio": 4.47, "shortPercentOfFloat": 0.0749, "impliedSharesOutstanding": 33197000, "bookValue": 3.533, "priceToBook": 1.1604868, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -98333000, "trailingEps": -3.09, "forwardEps": -2.77, "enterpriseToEbitda": -0.233, "52WeekChange": -0.7413249, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 4.1, "targetHighPrice": 28.0, "targetLowPrice": 16.0, "targetMeanPrice": 21.57143, "targetMedianPrice": 21.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 121518000, "totalCashPerShare": 3.661, "ebitda": -105137000, "totalDebt": 9924000, "quickRatio": 5.319, "currentRatio": 5.52, "debtToEquity": 8.494, "returnOnAssets": -0.46106, "returnOnEquity": -0.85366994, "grossProfits": -74091000, "freeCashflow": -48427376, "operatingCashflow": -81151000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LXEO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "exchange": "NGM", "messageBoardId": "finmb_625814286", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "postMarketTime": 1743205250, "regularMarketTime": 1743192002, "regularMarketChangePercent": -0.24331456, "regularMarketPrice": 4.1, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1699018200000, "postMarketChangePercent": 2.19513, "postMarketPrice": 4.19, "postMarketChange": 0.0900002, "regularMarketChange": -0.010000229, "regularMarketDayRange": "3.94 - 4.33", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 495929, "fiftyTwoWeekLowChange": 1.78, "fiftyTwoWeekLowChangePercent": 0.7672414, "fiftyTwoWeekRange": "2.32 - 19.5", "fiftyTwoWeekHighChange": -15.4, "fiftyTwoWeekHighChangePercent": -0.78974354, "fiftyTwoWeekChangePercent": -74.13249, "epsTrailingTwelveMonths": -3.09, "epsForward": -2.77, "epsCurrentYear": -3.092, "priceEpsCurrentYear": -1.3260026, "shortName": "Lexeo Therapeutics, Inc.", "longName": "Lexeo Therapeutics, Inc.", "fiftyDayAverageChange": 0.038700104, "fiftyDayAverageChangePercent": 0.009528995, "twoHundredDayAverageChange": -4.62345, "twoHundredDayAverageChangePercent": -0.5300025, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-11-03", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Lexeo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]